Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Immortal time bias in pharmaco-epidemiology
Oral options might increase their willingness to initiate and adhere to treatment, potentially broadening the pool of people who can benefit from [GLP-1] therapy. Maintenance therapy after weight loss For people whove already lost weight with an injectable GLP-1, switching to a pill may help maintain progress without continuing injections
Shipping & Notes
This research was supported by the Department of Defense (W81XWH-18-1-0206), The Hartwell Foundation, the Schwartz Research Fund and the National Institute of Diabetes and Digestive and Kidney Diseasesfunded Integrated Islet Distribution Program Award Initiative (to BPC)
Visceral fat in hypertension: influence on insulin resistance and beta-cell function
US$ 20.24
US$ 25.42
US$ 27.64
US$ 28.22
